NYSE$XRN

Global Medical REIT Inc · Q4 2021 earnings

Q4 2021 earnings · · Investor relations

Briefing

Announced financial results for the fourth quarter and invested $196 million in medical real estate during 2021.

Global Medical REIT reported a strong fourth quarter, with a 21.8% increase in rental revenue year-over-year to $30.3 million and net income attributable to common stockholders totaling $3.8 million, or $0.06 per diluted share. The company completed four acquisitions for $25.9 million and funded a $6.8 million expansion at its Mercy Rehabilitation Hospital. The portfolio was 97.5% occupied with an annualized base rent of $103.1 million.

  • Rental revenue increased 21.8% year-over-year to $30.3 million.
  • Net income attributable to common stockholders totaled $3.8 million, or $0.06 per diluted share.
  • Completed four acquisitions for an aggregate purchase price of $25.9 million.
  • Portfolio was 97.5% occupied with an annualized base rent of $103.1 million.

Headline financials

Total Revenue

$30.3M

Previous: $24.9M+21.8%
EPS (adj)

$0.24

Previous: $0.24+0.0%
WALT

7.1

Previous: 8.2-13.4%
Net Income

$3.8M

Previous: $1.1M+245.5%
Operating Income

$4.4M

Previous: $2.6M+69.2%
Gross Profit

$25.8M

Previous: $22.3M+15.7%
Cash & Equivalents

$2.11M

Previous: $85M-97.5%
Total Assets

$1.37B

Previous: $1B+37.0%
Stock-Based Comp

$1.24M

Previous: $1.93M-35.6%

Revenue & EPS history

Global Medical REIT · Revenue · Quarterly

$30.3M

Q4 2021+21.8%vs Q4 2020
Beat estimate in 9 of 16 quarters(56%)
ActualEstimate

Revenue by segment

Global Medical REIT · $38M total across 2 segments · Q2 2025

  • Rental Revenue
    $37.9M—
  • Other Income
    $89K—

Forward guidance

The company expects to reinvest the sales proceeds in 2022 for future acquisitions.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 18 quarterly earnings reports · overlaid with Q4 2021

Historical avgQ4 2021

+0.2%

Avg return

Earnings day

+0.9%

Avg return

5 days after

+1.1%

Avg return

30 days after

56%

22 / 39 earnings

Positive

+7.3%

Q4 2016

Best reaction

-9.8%

Q1 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q2 2025———
Q1 2026-9.2%-4.2%—
Q4 2025-1.6%-2.6%-13.2%
Q3 2025+1.8%+3.2%+1.7%
Q1 2025-9.8%-11.7%-17.0%
Q4 2024+3.8%+4.4%+3.1%
Q3 2024-2.6%-3.6%-7.4%
Q2 2024-1.8%-0.3%+1.0%
Q1 2024+3.4%+4.8%+8.4%
Q4 2023-5.6%-2.7%-5.7%
Q3 2023-1.8%-0.8%+11.7%
Q2 2023+3.5%+4.8%-1.5%
Q1 2023+0.8%+1.8%+1.9%
Q4 2022-4.0%-1.2%-13.0%
Q3 2022-0.9%+0.2%+12.3%
Q2 2022-0.5%-1.3%-11.0%
Q1 2022-5.3%-11.9%-12.5%
Q4 2021-3.2%-2.2%+1.9%
Q3 2021+1.6%+1.0%-2.5%
Q2 2021-0.7%-0.2%+3.7%
Q1 2021-1.2%+1.0%+5.2%
Q4 2020+1.6%+3.9%+0.2%
Q3 2020+2.0%+1.4%+7.2%
Q2 2020+4.8%+11.4%+11.6%
Q1 2020+7.0%+9.3%+26.0%
Q4 2019+4.7%-7.2%-41.1%
Q3 2019+2.3%+9.5%+22.4%
Q2 2019-0.7%+1.8%+5.0%
Q1 2019+1.4%+4.5%+7.1%
Q4 2018+0.8%+2.6%-2.0%
Q3 2018+2.2%+2.0%+6.4%
Q2 2018+4.3%+6.7%+12.2%
Q1 2018+2.6%-0.1%+4.6%
Q4 2017+5.8%+6.3%+3.9%
Q3 2017+3.1%+3.7%-2.8%
Q2 2017+0.7%+2.8%+2.8%
Q1 2017-1.2%+0.0%+0.3%
Q4 2016+7.3%+9.3%+17.1%
Q3 2016-8.5%-14.9%-0.2%
Q2 2016+1.1%+2.3%-5.0%
Q1 2016———
Q4 2015———
Q3 2015———
Q2 2015———
Q1 2015———
Q4 2014———
Q3 2014———
Q2 2014———
Q1 2014———
Q4 2013———
Q3 2013———
Q2 2013———
Q1 2013———
Q4 2012———
Q3 2012———
Q2 2012———
Q1 2011———
Q4 2011———

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro